Table 3.
Description of ACCEPT© treatment attribute dimension scores, presented as mean (SD)
| Multi item dimensions | Single-item dimension | ||||||
|---|---|---|---|---|---|---|---|
| N | Acceptance/Medication Inconvenience | Acceptance/Long-term Treatment | Acceptance/Regimen Constraints | Acceptance/Side effects | Acceptance/Effectiveness | Acceptance/Numerous Medications | |
| Type 2 diabetes | 669 | 80.0 (25.4) | 56.0 (21.7) | 67.0 (31.2) | 71.4 (32.7) | 67.0 (35.5) | 36.8% |
| Multiple sclerosis | 426 | 69.7 (31.8) | 57.8 (26.1) | 67.5 (28.0) | 60.9 (33.1) | 55.6 (38.2) | 20.7% |
| Ankylosing spondylitis | 297 | 67.6 (28.6) | 50.4 (23.7) | 63.1 (29.4) | 41.2 (33.5) | 52.5 (38.4) | 37.7% |
| Type 1 diabetes | 251 | 59.9 (29.3) | 48.2 (24.0) | 52.9 (34.9) | 68.5 (34.8) | 79.8 (29.8) | 31.1% |
| Fibromyalgia | 248 | 89.6 (16.8) | 47.4 (25.1) | 62.1 (32.2) | 51.5 (34.0) | 53.7 (35.9) | 52.4% |
| Rheumatoid arthritis | 215 | 75.6 (27.5) | 48.6 (26.1) | 67.5 (27.7) | 44.5 (34.9) | 57.3 (38.6) | 45.1% |
| Arthrosis | 163 | 90.7 (16.1) | 56.1 (23.5) | 76.7 (26.6) | 70.7 (33.4) | 59.8 (37.4) | 25.8% |
| Bipolar disorder | 143 | 90.4 (16.8) | 49.9 (23.2) | 62.1 (30.1) | 46.1 (32.8) | 67.0 (37.3) | 39.9% |
| Breast cancer | 137 | 86.5 (20.4) | 53.5 (23.7) | 71.1 (28.4) | 35.4 (29.8) | 37.7 (34.6) | 27.7% |
| Depression | 104 | 91.3 (16.9) | 48.8 (23.4) | 67.9 (30.3) | 60.4 (33.1) | 60.6 (38.7) | 39.4% |
| Lupus | 100 | 89.2 (16.5) | 46.3 (25.6) | 60.2 (31.9) | 52.1 (34.6) | 57.3 (35.3) | 45.0% |
| Crohn’s disease/ Ulcerative colitis | 98 | 72.9 (27.5) | 50.8 (26.8) | 67.2 (28.4) | 53.6 (33.3) | 62.2 (40.6) | 23.5% |
| COPD | 74 | 83.1 (21.8) | 53.5 (22.7) | 69.7 (29.7) | 77.8 (32.0) | 60.5 (36.0) | 27.0% |
| Psoriasis | 68 | 78.7 (22.4) | 49.1 (28.0) | 71.8 (23.8) | 74.6 (31.9) | 53.9 (37.6) | 11.8% |
| Parkinson’s disease | 65 | 88.5 (17.5) | 47.4 (25.9) | 56.8 (33.8) | 52.1 (32.2) | 54.9 (40.3) | 36.9% |
| Hypertension | 64 | 96.3 (7.8) | 61.3 (19.8) | 73.4 (26.5) | 81.4 (26.7) | 77.6 (31.3) | 20.3% |
| Asthma | 51 | 80.8 (22.7) | 51.3 (17.6) | 63.0 (28.1) | 70.4 (36.3) | 75.2 (32.9) | 39.2% |
| Epilepsy | 45 | 88.4 (21.0) | 52.8 (22.9) | 61.4 (28.9) | 56.9 (28.8) | 68.1 (37.4) | 24.4% |
| Myocardial infarction | 33 | 90.1 (18.8) | 47.7 (26.3) | 65.3 (33.1) | 54.2 (32.4) | 51.0 (36.5) | 54.5% |
| Other diseases | 942 | 84.9 (22.3) | 53.7 (25.5) | 67.8 (30.2) | 57.8 (35.5) | 60.7 (36.9) | 30.0% |
| Total | 4193 | 80.2 (25.7) | 52.7 (24.6) | 66.0 (30.4) | 58.9 (35.3) | 60.8 (37.4) | 33.2% |
In bold, three diseases with best level of acceptance; in italics three diseases with worst level of acceptance
ACCEPT© scores range from 0 to 100 for multi-item dimensions with a higher score indicating greater acceptance. The single item dimension “Acceptance/Numerous Medications” score is presented as the percentage of patients answering “I don’t find this easy to accept” from the original 3-point response scale common to all items